A Randomized Controlled Trial to Compare the Safety and Efficacy of Tadalafil and Tamsulosin in Relieving Double J Stent Related Symptoms

Table 4

Multiple regression analysis of mean ureteral stent symptom score at 1st week and 3rd week in three groups.

Variables	Group A Tadalafil		Group B Tamsulosin				Group C Placebo
				OR (CI)	value			OR (CI)	value
Urinary symptoms >20	24		29	0.65 (0.30–1.42)	0.28		0	86.82 (5.09–991.42)	<0.0001
Body pain >10	23		6	5.95 (2.16–16.37)	0.0006		1	40.25 (5.15–314.32)	<0.0001
Sexual health >5	22		2	19.25 (4.21–88.03)	<0.0001		1	35.93; (4.60–280.50)	<0.0001
General health >3	31		22	1.8 (0.86–4.13)	0.12		2	35.43 (7.76–161.84)	<0.0001
Work performance >2	27		27	0.96 (0.44–2.08)	0.92		13	3.07 (1.34–7.08)	0.008
Additional problems >1	19		9	2.69 (1.08–6.71)	0.03		8	3.0227 (1.18–7.77)	0.02